Annual Report under Regulation 34 of the SEBI (LODR) Regulations, 2015

Related Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹4.19

prior close

₹4.17

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+0.8% vs market

Pharmaceuticals peers, median of 149sector+0.0%+1.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.2

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7+0.8+0.8+0.0+1.7

Next day

-0.5+1.8-2.3+0.8-1.3

+0.0+1.2-1.2+0.5-0.5

+6.4+1.2+5.3+0.3+6.2

+5.0+1.6+3.4+0.4+4.6

+5.0+1.8+3.2+0.9+4.1

+4.5+2.1+2.4+1.4+3.1

15d

+1.4+3.1-1.7+1.7-0.2

-0.7+0.9-1.7-0.9+0.1

-6.0+3.2-9.2-0.8-5.2

-12.6-1.5-11.1-4.2-8.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenith Healthcare Ltd has submitted its 31st Annual Report for FY 2024-25 to BSE. The 31st Annual General Meeting is scheduled for 30th September 2025 at 10:30 AM via video conferencing, with remote e-voting open from 27th to 29th September 2025. Key agenda items include adoption of audited financial statements, re-appointment of Mr. Atul M. Thakkar as a director (retiring by rotation), appointment of Kamlesh M. Shah & Co. as Secretarial Auditors for a 5-year term (FY 2025-26 to 2029-30), and approval of a material related party transaction with Achyut Healthcare Limited for sale of API, raw materials and packing materials worth up to Rs. 100 crore during FY 2025-26. Achyut Healthcare is a related party because CMD Mahendra C. Raycha and Joint MD Akshit M. Raycha are also directors there, and the transaction exceeds the SEBI materiality threshold, requiring shareholder approval by special resolution.

Likely market impact

Routine regulatory compliance filing for shareholders to review. The Rs. 100 crore related party transaction with Achyut Healthcare is the key item needing shareholder nod, signaling continued inter-group business activity that investors should monitor for related-party risk concentration.